Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
AstraZeneca Stock Leads 3 Cash Flow Picks Trading Below Fair Value
Ionis Pharmaceuticals (IONS) Trial Setback Sparks Scrutiny, Is The 38% Undervaluation Case Still Credible?
Wealth Alliance LLC Has $1.73 Million Stock Holdings in Astrazeneca Plc $AZN
Lido Advisors LLC Cuts Stake in Astrazeneca Plc $AZN
Compound Planning Inc. Sells 24,013 Shares of Astrazeneca Plc $AZN - Markets Daily
Astrazeneca Plc $AZN Shares Sold by Compound Planning Inc.
Lonza Group Ltd (LONN) Gets a Buy from Bernstein
PNC Financial Services Group Inc. Sells 117,223 Shares of Astrazeneca Plc $AZN - Daily Political
Business Weekly Awards 2026: 44 shortlisted companies revealed for Cambridge Tech and Life Sciences showcase
Weekly Buzz: AZN, GSK JNJ Approvals; CUV Layoff, REGN, HALO, Samsun Deals, LLY, CLDX Data
Public Employees Retirement System of Ohio Buys 677,700 Shares of Astrazeneca Plc $AZN
Analysis-AstraZeneca 'magic' faces rare test after trial failure, share slide - AOL
UK Stocks That May Be Trading Below Their Estimated Value
How Eplontersen's Phase 3 Setback And Scrutiny At Ionis Pharmaceuticals (IONS) Has Changed Its Investment Story
Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study
AstraZeneca Stock Looks Undervalued on Cash Flow Alongside Two UK Shares
AstraZeneca immune from Covid-19 vaccine injury lawsuit | Courthouse News Service
Astrazeneca Plc $AZN Shares Sold by Glenview Trust Co - Markets Daily
AstraZeneca Wins EU Approval for Breast-Cancer Drug as U.S. Review Continues | Morningstar
Glenview Trust Co Trims Position in Astrazeneca Plc $AZN - Stock Observer
AZN Investors Have Opportunity to Join AstraZeneca PLC Fraud Investigation with the Schall Law Firm | Morningstar
Disease modification in lupus nephritis: towards a pathophysiology-based treatment paradigm
Advancing antibody drug conjugates in gastrointestinal cancers
AstraZeneca Stock And 2 Value Picks Trading Below Cash Flow Estimates
Parallel Advisors LLC Invests $1.72 Million in Astrazeneca Plc $AZN
Temasek Holdings Private Ltd Takes $70.89 Million Position in Astrazeneca Plc $AZN - Stock Observer
Astrazeneca Plc $AZN Shares Sold by Saturna Capital Corp - Daily Political
Does Eplontersen's Phase 3 Miss and Dravet Progress Change The Bull Case For Ionis (IONS)?
FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial
Single-nucleus multimodal spatial transcriptomics reveals spatial colocalization of neoantigen-expressing tumor cells and cognate T cells
PD-1 and PD-L1 Inhibitors Clinical Trial Pipeline Analysis Demonstrates 180+ Key Companies on the Horizon Expected to Transform the Oncology Space | DelveInsight
AstraZeneca Stock And 2 UK Shares Trading Below Cash Flow Value
Burling Wealth Partners LLC Buys Shares of 12,554 Astrazeneca Plc $AZN - Markets Daily
Former AstraZeneca and Novo Nordisk executives join ELRIG Scientific Advisory Board
Astrazeneca (AZN) Falls More Steeply Than Broader Market: What Investors Need to Know
AstraZeneca Stock And Two UK Value Shares Trading Below Cash Flow Estimates
Astrazeneca Plc $AZN Shares Sold by Boston Common Asset Management LLC
Astrazeneca Plc $AZN Shares Acquired by DekaBank Deutsche Girozentrale
Astrazeneca (AZN) to Release Quarterly Earnings on Monday
AZN Q2 2026 Earnings Report on 7/27/2026
Erste Group Bank Cuts Earnings Estimates for Astrazeneca
AstraZeneca inks $1.5 B deal with China's Dizal Pharma for novel oral EGFR inhibitor Zegfrovy for lung cancer
50,765 Shares in Astrazeneca Plc $AZN Purchased by S&CO Inc.
5,954,417 Shares in Astrazeneca Plc $AZN Purchased by SEB Asset Management AB
Swiss National Bank Takes $1.20 Billion Position in Astrazeneca Plc $AZN - Markets Daily
Jennison Associates LLC Sells 2,698,901 Shares of Astrazeneca Plc $AZN
6,174,666 Shares in Astrazeneca Plc $AZN Bought by Swiss National Bank - Stock Observer
10,918 Shares in Astrazeneca Plc $AZN Purchased by Spartan Wealth Advisory Services LLC - Daily Political
AstraZeneca Stock And 2 Cash Flow Picks Trading Below Fair Value
SEB Asset Management AB Makes New $1.16 Billion Investment in Astrazeneca Plc $AZN - Daily Political
Aurora Investment Counsel Takes $2.53 Million Position in Astrazeneca Plc $AZN
Assetmark Inc. Has $37.69 Million Stake in Astrazeneca Plc $AZN
Is a £500k Stocks and Shares ISA enough to retire in style?
Is NeoGenomics (NEO) Undervalued After Its FDA Approved PTEN Test Launch?
Immune correlates of risk for SARS-CoV-2 infection in children: a prospective, community-based cohort study
Overall survival according to timing of immune checkpoint inhibitors administration in patients with advanced cancer: results from a large single-centre cohort analysis
Abivax re-engages Centerview amid renewed takeover interest, La Lettre says
AstraZeneca Stock And Two UK Cash Flow Picks Trading Below Fair Value
The First Oral Cholesterol Pill Is Here. Which of These 5 Stocks Benefits Most?
SouthState Bank Corp Sells 63,327 Shares of Astrazeneca Plc $AZN
Barings LLC Makes New $27.79 Million Investment in Astrazeneca Plc $AZN
Astrazeneca Plc $AZN Stake Reduced by Nwam LLC - Daily Political
Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia
Attractive Growth Profile Positions AstraZeneca PLC (AZN) as Opportunity
Attractive Growth Profile Positions AstraZeneca PLC (AZN) as an Investment Bet
Astrazeneca Plc $AZN Position Lowered by Marks Group Wealth Management Inc
Principal Financial Group Inc. Decreases Position in Astrazeneca Plc $AZN
AZN: Trial Setbacks And Oncology Deals Will Shape Medium Term Credibility
Astrazeneca Plc $AZN Shares Sold by Marks Group Wealth Management Inc - Daily Political
ERN GENTURIS cancer surveillance guideline for individuals with PTEN hamartoma tumour syndrome (PHTS)
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial
Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage
Clinician expertise and prompt engineering enhance cancer information extraction in electronic health records by small language models
Checchi Capital Advisers LLC Decreases Stake in Astrazeneca Plc $AZN
169,590 Shares in Astrazeneca Plc $AZN Purchased by Maryland State Retirement & Pension System
Checchi Capital Advisers LLC Trims Stake in Astrazeneca Plc $AZN
Astrazeneca Plc $AZN Shares Sold by Calamos Advisors LLC
AMG National Trust Bank Has $4.72 Million Stake in Astrazeneca Plc $AZN - Zolmax
Calamos Advisors LLC Trims Position in Astrazeneca Plc $AZN - Stock Observer
Recent Research Analysts' Ratings Changes for Astrazeneca (AZN) - Daily Political
Maryland State Retirement & Pension System Buys Shares of 169,590 Astrazeneca Plc $AZN - Daily Political
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
Promising Manufacturing Stocks To Research - July 14th - Zolmax
4568: Tumor Agnostic Oncology Approvals In Europe Will Drive Future Upside Potential
Sequoia Financial Advisors LLC Sells 19,406 Shares of Astrazeneca Plc $AZN - Zolmax
HSBC loses conviction in leading drugmaker, forecasts 'tough path' ahead
IP Federation elects Philips licensing leader as new president
Samsung Electronics denies report that it is exploring US listing
AstraZeneca Secures $1.5 Billion Licensing Deal for Revolutionary Lung Cancer Drug Zegfrovy from China's Dizal Pharma, ETPharma
Astrazeneca Plc $AZN Shares Bought by Diversify Wealth Management LLC
Bleakley Financial Group LLC Sells 23,183 Shares of Astrazeneca Plc $AZN
AstraZeneca to pay up to $1.5bn for global rights to lung cancer pill
AstraZeneca Enters Exclusive License Deal For Lung Cancer Drug Zegfrovy For Up to $1.5 Billion | Morningstar
Does NeoGenomics (NEO) New PTEN CDx Move Reveal a Deeper Precision Oncology Strategy Shift?
AstraZeneca to license lung cancer drug from China's Dizal Pharmaceutical
Dizal Announces Global Exclusive License Agreement with AstraZeneca for Zegfrovy
